PCM
Perkins Capital Management Portfolio holdings
AUM
$99.5M
This Quarter Return
+22.49%
1 Year Return
+49.19%
3 Year Return
+174.89%
5 Year Return
+322.89%
10 Year Return
–
AUM
$167M
AUM Growth
+$167M
(+19%)
Cap. Flow
+$9.05M
Cap. Flow
% of AUM
5.44%
Top 10 Holdings %
Top 10 Hldgs %
31.97%
Holding
144
New
17
Increased
44
Reduced
38
Closed
12
Top Buys
| 1 |
Venus Concept
VERO
|
$1.73M |
| 2 |
Champions Oncology
CSBR
|
$1.36M |
| 3 |
Sensus Healthcare
SRTS
|
$1.26M |
| 4 |
IRIDEX
IRIX
|
$990K |
| 5 |
IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
|
$983K |
Top Sells
| 1 |
IPAS
Ipass Inc Common Stock
IPAS
|
$3.04M |
| 2 |
Tactile Systems Technology
TCMD
|
$1.29M |
| 3 |
IVTY
Invuity, Inc
IVTY
|
$1.22M |
| 4 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
$1.08M |
| 5 |
Cibus
CBUS
|
$833K |
Sector Composition
| 1 | Healthcare | 60.63% |
| 2 | Technology | 11.46% |
| 3 | Industrials | 6.55% |
| 4 | Communication Services | 4.39% |
| 5 | Consumer Discretionary | 3.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Axogen
AXGN
$743M
| $13.2M | 7.94% | 359,000 -6,675 | -2% | -$246K |
|
2
Vericel Corp
VCEL
$1.83B
| $7.78M | 4.67% | 549,750 -2,350 | -0.4% | -$33.3K |
|
3
CareDx
CDNA
$727M
| $6.09M | 3.66% | 211,060 +9,500 | +5% | +$274K |
|
4
Abbott
ABT
$231B
| $5.65M | 3.39% | 77,050 | – | – |
|
5
NeoGenomics
NEO
$1.13B
| $4.36M | 2.62% | 283,900 -5,900 | -2% | -$90.6K |
|
6
Idexx Laboratories
IDXX
$51.8B
| $3.33M | 2% | 13,350 | – | – |
|
|
7
Sensus Healthcare
SRTS
$55.7M
| $3.33M | 2% | 396,836 +149,950 | +61% | +$1.26M |
|
8
Apyx Medical
APYX
$75.3M
| $3.3M | 1.98% | 465,350 +64,650 | +16% | +$459K |
|
|
9
Champions Oncology
CSBR
$93.8M
| $3.16M | 1.89% | 180,600 +77,600 | +75% | +$1.36M |
|
|
TEUM
10
DELISTED
Pareteum Corporation
TEUM
| $3.03M | 1.82% | 1,008,729 +190,000 | +23% | +$570K |
|
11
Pfizer
PFE
$141B
| $2.98M | 1.79% | 67,569 +400 | +0.6% | +$17.6K |
|
12
OptimizeRx
OPRX
$335M
| $2.8M | 1.68% | 155,450 -1,668 | -1% | -$30K |
|
|
CSII
13
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.71M | 1.63% | 69,250 +900 | +1% | +$35.2K |
|
14
AtriCure
ATRC
$1.84B
| $2.67M | 1.6% | 76,250 +5,000 | +7% | +$175K |
|
15
Eli Lilly
LLY
$657B
| $2.53M | 1.52% | 23,610 | – | – |
|
16
LeMaitre Vascular
LMAT
$2.16B
| $2.5M | 1.5% | 64,400 -150 | -0.2% | -$5.81K |
|
|
17
Tactile Systems Technology
TCMD
$297M
| $2.45M | 1.47% | 34,505 -18,119 | -34% | -$1.29M |
|
18
Magnite
MGNI
$3.7B
| $2.45M | 1.47% | 680,500 +159,000 | +30% | +$572K |
|
19
BioLife Solutions
BLFS
$1.2B
| $2.44M | 1.46% | 139,150 -18,650 | -12% | -$326K |
|
20
Microsoft
MSFT
$3.77T
| $2.38M | 1.43% | 20,810 | – | – |
|
|
VRAY
21
DELISTED
ViewRay, Inc.
VRAY
| $2.22M | 1.33% | 237,550 +80,200 | +51% | +$751K |
|
22
Tile Shop Holdings
TTSH
$278M
| $2.11M | 1.27% | 295,600 +40,600 | +16% | +$290K |
|
23
SPS Commerce
SPSC
$4.18B
| $2.08M | 1.25% | 20,950 +100 | +0.5% | +$9.92K |
|
24
Veracyte
VCYT
$2.39B
| $2.02M | 1.21% | 211,555 +60,700 | +40% | +$580K |
|
25
CryoPort
CYRX
$444M
| $2M | 1.2% | 156,400 -500 | -0.3% | -$6.4K |
|